Go to menu
Go main contents
Go main menu
Go copyright
homearrowUS OfficearrowNews

News

You can Check the U.S. business of AJU IB INVESTMEMT

line

Bellicum Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of the Underwriters’ Option

Site : learn more

Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs

Site : learn more

Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug

Site : learn more

Grabbing a quick $55M venture round, Bellicum Pharma ponders an IPO

Site : learn more

Molecular Templates Announces Completion of $12M Series C Financing

Site : learn more